中东和非洲酶替代疗法市场预测至 2028 年 – COVID-19 影响和区域分析 – 按酶类型（Alglucosidase Alfa、Agalsidase Beta、Imiglucerase、Idursulfase、Galsulfase、Velalucerase Alfa 和其他酶）、治疗条件（戈谢病、法布里病、MPS、庞贝氏病、SCID 和其他治疗病症）、给药途径（肠胃外和口服）和最终用户（医院、输液中心等）

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

No. of Pages: 162    |    Report Code: BMIRE00027293    |    Category: Life Sciences

Explore in Your Language
English Arabic French German Italian Japanese Korean Spanish
Middle East & Africa Enzyme Replacement Therapy Market
Free Sample Buy Now

中东和中东地区的酶替代疗法市场非洲预计将从2022年的2.9732亿美元增长到2028年的3.8656亿美元；预计 2022 年至 2028 年复合年增长率为 4.5%。

溶酶体贮积病 (LSD) 患病率上升

溶酶体贮积症（LSD）的主要原因是负责编码溶酶体酶的基因突变。 LSD 的特征是一种先天性代谢错误，导致酶的缺失或缺乏。婴儿和儿童很容易患上LSD，因为儿童可以从父母一方或双方遗传有缺陷的基因。然而，自过去十年以来，这种模式一直在发生变化，LSD 在成年人中更为常见。 LSD 可导致大约 70 种疾病，包括戈谢病、尼曼-匹克病、法布里病、泰-萨克斯病、粘多糖贮积症 (MPS) 疾病和庞贝病。这些疾病单独来看很少见，但总的来说却非常普遍，影响五千分之一的活产儿。许多LSD 的治疗方法有限。然而，针对少数 LSD 的疗法和疗法正在取得进展，从而显着改善了受影响者的生活质量。例如，酶替代疗法已被证明对 I、II 和 III 型戈谢病患者有效。酶替代疗法有助于改善贫血症状、血小板计数低和骨骼问题，并有助于减少肝脏和脾脏肿大。因此，LSD 的流行率上升和治愈该疾病的有限疗法正在推动中东和中东地区酶替代疗法市场的增长。非洲。

 

 

市场概况

中东和中东地区非洲酶替代疗法市场分为沙特阿拉伯、南非、阿联酋以及中东和非洲其他地区。非洲。沙特阿拉伯是该地区2021年最大的酶替代疗法市场。根据2020年《应用血液学杂志》上发表的一篇文章，其患病率高于目前现有文献报道的水平。这可能主要是由于血缘关系的比例很高，特别是在部落之间。在沙特阿拉伯，戈谢病的诊断率很低。有时会被误诊为其他血液疾病。此外，根据上述同一研究，在沙特阿拉伯，约有 75 名患者被诊断患有戈谢病；然而，戈谢病的诊断不足或误诊存在巨大差距。由于近亲结婚率高且每个家庭的怀孕率高，预计发病率会更高。酶替代疗法（ERT）是戈谢病的有效治疗方法。由国际戈谢协作组 (ICGG) 赞助的戈谢登记处的大量证据表明，酶替代疗法可逆转戈谢病的内脏和血液学表现，并缓解骨骼症状，从而提高生活质量。此外，沙特阿拉伯政府启动了“沙特愿景2030”计划，以减少对石油的依赖并使包括医疗保健在内的其他行业实现多元化，这导致医疗保健服务的显着发展和先进技术的高采用率。在这一愿景下，沙特阿拉伯的大学贡献了全国93%的科研产出，推动了教育部推动研究和创新体系的努力。此外，药物研发和临床试验在改善医疗保健、直接造福患者以及为沙特阿拉伯更广泛的患者提供最新、最伟大的制药行业进步方面发挥着至关重要的作用。因此，上述因素正在推动沙特阿拉伯酶替代疗法市场的增长。

 

 中东和中东地区;非洲酶替代疗法市场收入及预测至 2028 年（百万美元）

 

中东和中东地区非洲酶替代疗法市场细分

中东和非洲非洲酶替代疗法市场按酶类型、治疗条件、给药途径、最终用户和国家细分。

  • 根据酶类型，市场分为阿糖苷酶 alfa、阿加糖苷酶 beta、伊米苷酶、艾杜硫酶、半乳糖酶、维拉苷酶 alfa 和其他酶。其他酶细分市场在 2022 年占据最大的市场份额。
  • 根据治疗条件，市场分为戈谢病、< /span>法布里氏病、MPS、庞贝氏病、SCID以及其他治疗病症。 戈谢病在 2022 年占据最大的市场份额。
  • 就给药途径而言，市场是分为肠外和口服。 注射剂细分市场在 2022 年占据了更大的市场份额。
  • 从最终用户的角度来看，市场已细分进入医院、输液中心等。 2022 年，医院细分市场占据最大市场份额。
  • 根据国家/地区，市场分为沙特阿拉伯、南非、阿联酋以及中东其他地区和地区。非洲。沙特阿拉伯在 2022 年占据市场主导地位。

赛诺菲；生物海洋制药公司；武田制药有限公司；艾伯维公司；杨森制药（强生服务公司）；亚力兄制药公司（阿斯塔捷利康）；之友治疗公司； Recordati SpA； Recordati SpA； CHIESI farmaceutici SpA；和辉瑞公司是该地区酶替代疗法市场的领先公司之一。



Middle East & Africa Enzyme Replacement Therapy Strategic Insights

Strategic insights for Middle East & Africa Enzyme Replacement Therapy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-enzyme-replacement-therapy-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Enzyme Replacement Therapy Report Scope

Report Attribute Details
Market size in 2022 US$ 297.32 Million
Market Size by 2028 US$ 386.56 Million
Global CAGR (2022 - 2028) 4.5%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By 酶类型
  • 阿糖苷酶 α
  • 阿加糖苷酶 β
  • 伊米苷酶
  • 艾杜尔硫酸酶
  • 加糖硫酸酶
  • 维拉苷酶 α
  • 其他酶
By 治疗条件
  • 戈谢病
  • 法布里病
  • MPS
  • 庞贝病
  • 严重联合免疫缺陷症
  • 其他治疗条件
By 给药途径
  • 肠外
  • 口服
By 最终用户
  • 医院
  • 输液中心
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Sanofi.
  • BioMarine Pharmaceutical Inc.
  • Takeda Pharmaceutical Company Limited.
  • AbbVie Inc.
  • Janssen Pharmaceutical ( Johnson & Johnson Services,Inc.).
  • Alexion Pharmaceutical, Inc.(AstaZeneca).
  • Amicus Therapeutics.
  • Recordati S.p.A.
  • CHIESI farmaceutici S.p.A.
  • Pfizer Inc.
    		•
    Get more information on this report

    Middle East & Africa Enzyme Replacement Therapy Regional Insights

    The regional scope of Middle East & Africa Enzyme Replacement Therapy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-enzyme-replacement-therapy-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - Middle East & Africa Enzyme Replacement Therapy Market

    1. Sanofi.
    2. BioMarine Pharmaceutical Inc.
    3. Takeda Pharmaceutical Company Limited.
    4. AbbVie Inc.
    5. Janssen Pharmaceutical ( Johnson & Johnson Services,Inc.).
    6. Alexion Pharmaceutical, Inc.(AstaZeneca).
    7. Amicus Therapeutics.
    8. Recordati S.p.A.
    9. CHIESI farmaceutici S.p.A.
    10. Pfizer Inc.
    Frequently Asked Questions
    How big is the Middle East & Africa Enzyme Replacement Therapy Market?

    The Middle East & Africa Enzyme Replacement Therapy Market is valued at US$ 297.32 Million in 2022, it is projected to reach US$ 386.56 Million by 2028.

    What is the CAGR for Middle East & Africa Enzyme Replacement Therapy Market by (2022 - 2028)?

    As per our report Middle East & Africa Enzyme Replacement Therapy Market, the market size is valued at US$ 297.32 Million in 2022, projecting it to reach US$ 386.56 Million by 2028. This translates to a CAGR of approximately 4.5% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Enzyme Replacement Therapy Market report typically cover these key segments-

  • 酶类型 (阿糖苷酶 α, 阿加糖苷酶 β, 伊米苷酶, 艾杜尔硫酸酶, 加糖硫酸酶, 维拉苷酶 α, 其他酶)
  • 治疗条件 (戈谢病, 法布里病, MPS, 庞贝病, 严重联合免疫缺陷症, 其他治疗条件)
  • 给药途径 (肠外, 口服)

    • What is the historic period, base year, and forecast period taken for Middle East & Africa Enzyme Replacement Therapy Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Enzyme Replacement Therapy Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
    • Who are the major players in Middle East & Africa Enzyme Replacement Therapy Market?

    The Middle East & Africa Enzyme Replacement Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Sanofi.
  • BioMarine Pharmaceutical Inc.
  • Takeda Pharmaceutical Company Limited.
  • AbbVie Inc.
  • Janssen Pharmaceutical ( Johnson & Johnson Services,Inc.).
  • Alexion Pharmaceutical, Inc.(AstaZeneca).
  • Amicus Therapeutics.
  • Recordati S.p.A.
  • CHIESI farmaceutici S.p.A.
  • Pfizer Inc.
    • Who should buy this report?

    The Middle East & Africa Enzyme Replacement Therapy Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Enzyme Replacement Therapy Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Request Free Sample Buy Now
    middle-east-and-africa-enzyme-replacement-therapy-market